Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 20, 2024 07:45 ET
Infrared Sauna Use in UCSF Clinical Trial Shows Promise in Combating Depression
In conjunction with May as Mental Health Awareness Month, preliminary results from a University of California, San Francisco (UCSF) clinical trial combining heat exposure with psychotherapy sessions showed reductions in depression. The study, led...
May 20, 2024 07:35 ET
Alta Equipment Group Announces Proposed Private Offering of $500 Million of Senior Secured Second Lien Notes
Alta Equipment Group Inc. (NYSE: ALTG) (“Alta” or the “Company”), today announced that it intends to offer, subject to market and other conditions, $500 million in aggregate principal amount of its senior secured second lien notes due 2029 in a...
May 20, 2024 07:30 ET
Leading Proxy Advisory Firms Recommend Shareholders Vote “FOR” All of Crown Castle’s Director Nominees
Crown Castle Inc. (NYSE: CCI) (“Crown Castle” or the “Company”) today announced that proxy advisory firm Egan-Jones has joined Institutional Shareholder Services (“ISS”) in recommending that shareholders vote on the WHITE proxy card or voting...
May 20, 2024 07:30 ET
Agrify Corporation Mutually Agrees to Terminate Plan to Merge with Nature’s Miracle
Agrify Corporation (Nasdaq:AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that Agrify Corporation and Nature’s Miracle Holdings Inc. (NASDAQ: NMHI)...
May 20, 2024 07:30 ET
BrightSpring Health Services Announces Onco360® Was Selected as National Pharmacy Partner for OJEMDA™
BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud that its company, Onco360®, one of the nation’s largest independent oncology pharmacies, is being selected as a pharmacy partner by Day One...
May 20, 2024 07:30 ET
Nexxen Reports Results for the First Quarter Ended March 31, 2024
Nexxen International Ltd. (AIM/NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, unified advertising technology platform with deep expertise in video and Connected TV (“CTV”), announced today its financial results for the first quarter...
May 20, 2024 07:30 ET
Reunion Neuroscience Announces Publication of Results from Early Preclinical Studies Demonstrating the Potential of RE104 for Development in Depressive Disorders
Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to pushing the boundaries of neuroscience, today announced the publication of the results of preclinical studies in ACS Chemical Neuroscience that validate the...
May 20, 2024 07:30 ET
SL Green Realty Corp. Announces Common Stock Dividend
SL Green Realty Corp. (NYSE:SLG), Manhattan’s largest office landlord, today announced that its board of directors has declared a monthly ordinary dividend of $0.25 per share of common stock, which is the equivalent of an annualized dividend of...
May 20, 2024 07:05 ET
Mesa Air Group Reports First Quarter Fiscal 2024 Results
Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today reported first quarter fiscal 2024 financial and operating results. First Quarter Fiscal 2024 Update: Total operating revenues of $118.8 millionPre-tax loss of $57.0 million, net...
May 20, 2024 07:03 ET
Nicole Robinson Appointed President of DataPath Inc.
Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that Nicole Robinson has been appointed as President of DataPath. Ms. Robinson is an...
May 20, 2024 07:03 ET
Wugen Announces RMAT and PRIME Designations for WU-CART-007 to Accelerate Regulatory Reviews and Plans to Present Positive Phase 2 Study Findings at European Hematology Association (EHA) 2024 in June
Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies for the treatment of hematological and solid tumor malignancies, today announced receipt of two new regulatory designations for its...
May 20, 2024 07:00 ET
Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Arun Upadhyay, PhD, Chief Scientific Officer, Head...
May 20, 2024 07:00 ET
Aveanna to Participate at the UBS Healthcare Services Cape Cod Summit and Jefferies Global Healthcare Conference
Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the UBS Healthcare Services Cape Cod Summit in Chatham, MA on Tuesday, June 4, 2024, and the Jefferies Global Healthcare Conference in...
May 20, 2024 07:00 ET
Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024
Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced the Company will present...
May 20, 2024 07:00 ET
Arqit Quantum Inc. Announces Financial and Operational Results for the First Half of Fiscal Year 2024
Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (“Arqit”), a leader in quantum safe encryption, today announced its operational and financial results for the six months ended 31 March 2024. Recent Operational Highlights Arqit sells Symmetric Key...
May 20, 2024 07:00 ET
Children International Hosts Ecuadorian Students in Kansas City for Global Finals of ‘Destination Imagination’ Tournament
Children International, a Kansas City, Mo.-based nonprofit dedicated to breaking the cycle of generational poverty worldwide, proudly announces the arrival of a team of six exceptional youths from Ecuador to compete in the esteemed global finals of...
May 20, 2024 07:00 ET
ECARX Announces First Quarter 2024 Unaudited Financial Results
ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced unaudited financial results for the quarter ended March 31, 2024. “The strong growth momentum that we picked up last year continued...
May 20, 2024 07:00 ET
Enlight Announces Participation at Upcoming JP Morgan and Roth MKM Investor Conferences
Enlight Renewable Energy (“Enlight”) (NASDAQ: ENLT, TASE: ENLT), a leading global renewable energy platform, today announced the Company will participate in two upcoming investor conferences. JP Morgan Energy, Power and Renewables Conference,...
May 20, 2024 07:00 ET
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference
Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, yesterday...